212 related articles for article (PubMed ID: 26375812)
1. Potassium channels related to primary aldosteronism: Expression similarities and differences between human and rat adrenals.
Chen AX; Nishimoto K; Nanba K; Rainey WE
Mol Cell Endocrinol; 2015 Dec; 417():141-8. PubMed ID: 26375812
[TBL] [Abstract][Full Text] [Related]
2. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.
Zhou J; Lam B; Neogi SG; Yeo GS; Azizan EA; Brown MJ
Hypertension; 2016 Dec; 68(6):1424-1431. PubMed ID: 27777363
[TBL] [Abstract][Full Text] [Related]
4. Human adrenal glomerulosa cells express K2P and GIRK potassium channels that are inhibited by ANG II and ACTH.
Enyeart JJ; Enyeart JA
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C158-C175. PubMed ID: 34038243
[TBL] [Abstract][Full Text] [Related]
5. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
Gomez-Sanchez CE; Oki K
Endocrinology; 2014 Jan; 155(1):47-55. PubMed ID: 24248457
[TBL] [Abstract][Full Text] [Related]
6. Primary aldosteronism and potassium channel mutations.
Stowasser M
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):170-9. PubMed ID: 23426162
[TBL] [Abstract][Full Text] [Related]
7. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
8. Effect of Dietary Sodium Modulation on Pig Adrenal Steroidogenesis and Transcriptome Profiles.
Vohra T; Kemter E; Sun N; Dobenecker B; Hinrichs A; Burrello J; Gomez-Sanchez EP; Gomez-Sanchez CE; Wang J; Kinker IS; Teupser D; Fischer K; Schnieke A; Peitzsch M; Eisenhofer G; Walch A; Reincke M; Wolf E; Williams TA
Hypertension; 2020 Dec; 76(6):1769-1777. PubMed ID: 33070662
[TBL] [Abstract][Full Text] [Related]
9. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N
J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
[TBL] [Abstract][Full Text] [Related]
10. NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.
Maniero C; Garg S; Zhao W; Johnson TI; Zhou J; Gurnell M; Brown MJ
Hypertension; 2017 Aug; 70(2):357-364. PubMed ID: 28584012
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Histopathologic Intertumor Heterogeneity in Primary Aldosteronism.
Omata K; Yamazaki Y; Nakamura Y; Anand SK; Barletta JA; Sasano H; Rainey WE; Tomlins SA; Vaidya A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1792-1796. PubMed ID: 28368480
[TBL] [Abstract][Full Text] [Related]
12. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
Charmandari E; Sertedaki A; Kino T; Merakou C; Hoffman DA; Hatch MM; Hurt DE; Lin L; Xekouki P; Stratakis CA; Chrousos GP
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1532-9. PubMed ID: 22628607
[TBL] [Abstract][Full Text] [Related]
13. ANO4 (Anoctamin 4) Is a Novel Marker of Zona Glomerulosa That Regulates Stimulated Aldosterone Secretion.
Maniero C; Scudieri P; Haris Shaikh L; Zhao W; Gurnell M; Galietta LJV; Brown MJ
Hypertension; 2019 Nov; 74(5):1152-1159. PubMed ID: 31564164
[TBL] [Abstract][Full Text] [Related]
14. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
Felizola SJ; Maekawa T; Nakamura Y; Satoh F; Ono Y; Kikuchi K; Aritomi S; Ikeda K; Yoshimura M; Tojo K; Sasano H
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():410-6. PubMed ID: 25151951
[TBL] [Abstract][Full Text] [Related]
15. Novel genetic determinants of adrenal aldosterone regulation.
Azizan EA; Brown MJ
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):209-17. PubMed ID: 26992195
[TBL] [Abstract][Full Text] [Related]
16. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Velarde-Miranda C; Gomez-Sanchez EP; Gomez-Sanchez CE
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):895-901. PubMed ID: 23829355
[TBL] [Abstract][Full Text] [Related]
17. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
Scholl UI; Lifton RP
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
[TBL] [Abstract][Full Text] [Related]
18. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract][Full Text] [Related]
19. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.
Yamazaki Y; Nakamura Y; Omata K; Ise K; Tezuka Y; Ono Y; Morimoto R; Nozawa Y; Gomez-Sanchez CE; Tomlins SA; Rainey WE; Ito S; Satoh F; Sasano H
J Clin Endocrinol Metab; 2017 Apr; 102(4):1182-1192. PubMed ID: 28388725
[TBL] [Abstract][Full Text] [Related]
20. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation.
Bandulik S; Penton D; Barhanin J; Warth R
Horm Metab Res; 2010 Jun; 42(6):450-7. PubMed ID: 20049674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
